The continuing evolution of COVID-19 imaging pathways in the UK: a British Society of Thoracic Imaging expert reference group update

In December 2019, Wuhan City (Hubei Province, China) reported a febrile respiratory tract illness of unknown origin in a cluster of patients. Bronchoalveolar lavage of the patients isolated a novel strain of coronavirus (SARS-coronavirus-2 [SARS-CoV-2]) as the pathogen.1 The pulmonary infection caused by SARS-CoV-2 was named coronavirus disease 2019 (COVID-19) by the World Health Organization (WHO). Despite the imposition of strict quarantine rules and restricted travel within and from China, the infection has spread rapidly across the globe, with continuing escalation in the UK, necessitating a plan by NHS England to build several temporary “Nightingale” hospitals (of up to 4,000 beds each), to provide mass-scale extra capacity.
Source: Clinical Radiology - Category: Radiology Authors: Tags: Editorial Source Type: research